| Product Code: ETC10434799 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Respiratory Infectious Disease Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Respiratory Infectious Disease Diagnostics Market - Industry Life Cycle |
3.4 Israel Respiratory Infectious Disease Diagnostics Market - Porter's Five Forces |
3.5 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume Share, By Target Pathogen, 2021 & 2031F |
3.8 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Israel Respiratory Infectious Disease Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Respiratory Infectious Disease Diagnostics Market Trends |
6 Israel Respiratory Infectious Disease Diagnostics Market, By Types |
6.1 Israel Respiratory Infectious Disease Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.1.4 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Antigen Testing, 2021 - 2031F |
6.1.5 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Serology Testing, 2021 - 2031F |
6.2 Israel Respiratory Infectious Disease Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Molecular Diagnostics, 2021 - 2031F |
6.2.3 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Rapid Immunoassay, 2021 - 2031F |
6.2.4 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Antibody Detection, 2021 - 2031F |
6.3 Israel Respiratory Infectious Disease Diagnostics Market, By Target Pathogen |
6.3.1 Overview and Analysis |
6.3.2 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Influenza, COVID-19, 2021 - 2031F |
6.3.3 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By RSV, Tuberculosis, 2021 - 2031F |
6.3.4 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By SARS-CoV-2, 2021 - 2031F |
6.4 Israel Respiratory Infectious Disease Diagnostics Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Laboratories, 2021 - 2031F |
6.4.3 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 Israel Respiratory Infectious Disease Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
7 Israel Respiratory Infectious Disease Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Respiratory Infectious Disease Diagnostics Market Export to Major Countries |
7.2 Israel Respiratory Infectious Disease Diagnostics Market Imports from Major Countries |
8 Israel Respiratory Infectious Disease Diagnostics Market Key Performance Indicators |
9 Israel Respiratory Infectious Disease Diagnostics Market - Opportunity Assessment |
9.1 Israel Respiratory Infectious Disease Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Respiratory Infectious Disease Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Israel Respiratory Infectious Disease Diagnostics Market Opportunity Assessment, By Target Pathogen, 2021 & 2031F |
9.4 Israel Respiratory Infectious Disease Diagnostics Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Israel Respiratory Infectious Disease Diagnostics Market - Competitive Landscape |
10.1 Israel Respiratory Infectious Disease Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Respiratory Infectious Disease Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here